ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” fourth quarter 2024 ...
MyOme, Inc., a leading clinical whole genome testing and polygenic risk modelling (PRS) company, is proud to announce the launch of its coronary artery disease (CAD) PRS product ? Integrated PRS, CAD ...
The intersection of Web3, AI, and blockchain is rapidly evolving, and few are pushing the boundaries like Mete Al, founder of ...
The king of the elevated non-dress shirt has now teamed with the king of the 'if you have to wear shoes, wear as little shoe ...
Early signs from the field trial indicate that two new vaccines protect hens against H5N1, but it is too soon to draw firm ...